Zomedica Corp (AMEX: ZOM) is -39.86% lower on its value in year-to-date trading and has touched a low of $0.12 and a high of $0.23 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ZOM stock was last observed hovering at around $0.12 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $0.12, the stock is -2.64% and -5.42% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.77 million and changing 0.33% at the moment leaves the stock -13.87% off its SMA200. ZOM registered -34.92% loss for a year compared to 6-month loss of -28.55%. The firm has a 50-day simple moving average (SMA 50) of $0.12754 and a 200-day simple moving average (SMA200) of $0.139875.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -8.72% gain in the last 1 month and extending the period to 3 months gives it a -18.15%, and is -0.66% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.37% over the week and 2.34% over the month.
Zomedica Corp (ZOM) has around 144 employees, a market worth around $117.98M and $26.08M in sales. Profit margin for the company is -214.70%. Distance from 52-week low is 1.01% and -47.31% from its 52-week high. The company has generated returns on investments over the last 12 months (-26.63%).
with sales reaching $6.26M over the same period., but quarterly earnings will post 35.40% year-over-year. Quarterly sales are estimated to grow 14.20% in year-over-year returns.
Zomedica Corp (ZOM) Top Institutional Holders
102.0 institutions hold shares in Zomedica Corp (ZOM), with institutional investors hold 8.80% of the company’s shares. The shares outstanding are 979.95M, and float is at 962.51M with Short Float at 5.31%. Institutions hold 8.64% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 29.93 million shares valued at $382.18 million. The investor’s holdings represent 3.054% of the ZOM Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 26.21 million shares valued at $334.65 million to account for 2.6742 of the shares outstanding. The other top investors are FMR LLC which holds 25.88 million shares representing 2.6405% and valued at over $330.43 million, while DRAGONEER INVESTMENT GROUP, LLC holds 2.2573 of the shares totaling 22.12 million with a market value of $282.47 million.
Zomedica Corp (ZOM) Insider Activity
The most recent transaction is an insider purchase by HEATON LARRY C II, the company’s CEO. SEC filings show that HEATON LARRY C II bought 100,000 shares of the company’s common stock on Sep 05 ’24 at a price of $0.12 per share for a total of $12500.0. Following the purchase, the insider now owns 0.4 million shares.
Zomedica Corp disclosed in a document filed with the SEC on Aug 28 ’24 that POWERS JOHNNY D (Director) bought a total of 100,000 shares of the company’s common stock. The trade occurred on Aug 28 ’24 and was made at $0.13 per share for $12900.0. Following the transaction, the insider now directly holds 2.33 million shares of the ZOM stock.
Still, SEC filings show that on Aug 20 ’24, Blair Anthony K (COO) acquired 100,000 shares at an average price of $0.14 for $14200.0. The insider now directly holds 250,000 shares of Zomedica Corp (ZOM).
